ArticleScientific reports2025
In-vitro antimicrobial activity of Jatropha variegata Vahl. (Euphorbiaceae) against some pathogenic microbes isolated from clinical samples in Ibb City, Yemen.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the in-vitro antimicrobial activity of Jatropha variegata against pathogenic microbes isolated from clinical samples in Ibb City. Fresh samples of leaves and stems were collected from various locations in Ibb, Yemen. The well diffusion method was employed to evaluate the antimicrobial activity of the plant extracts against specific bacteria and Candida. The phytochemical evaluation of Jatropha variegata leaves and stems revealed that tannins and sterols were most concentrated in the ethanolic extract. The leaves of Jatropha variegata exhibited notable antibacterial activity, producing inhibition zones of 18 mm against Staphylococcus aureus, and 15 mm against both Escherichia coli and Pseudomonas aeruginosa. In contrast, Enterobacter spp., Klebsiella spp., and Proteus spp. displayed resistance to the leaf extract. The minimum inhibitory concentration (MIC) of the stem extract was 100 mg/mL for Staphylococcus aureus, Escherichia coli, Salmonella spp., and Candida spp. For the leaf extract, the MIC was higher, "400 and 500 mg/mL" for Staphylococcus aureus and Pseudomonas aeruginosa, respectively, while remaining 100 mg/mL for Escherichia coli, Salmonella spp., and Candida spp. The minimum bactericidal concentration (MBC) of the stem extract was 500 mg/mL against Staphylococcus aureus and 100 mg/mL against Salmonella spp. Notably, the combined leaf and stem extracts demonstrated enhanced antimicrobial efficacy, evidenced by larger inhibition zones and improved MIC and MBC profiles, highlighting a potential synergistic effect.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.